Researchers have discovered a protein that is crucial to the operation of numerous novel cancer medicines. The discovery, according to the researchers, will probably help with efforts to optimize the use of immunotherapies against a number of difficult tumors.
For the first time, scientists have described a special molecular mechanism of the early phases of programmed cell death, often known as apoptosis, a process that is essential in the prevention of cancer.
Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumour suppressors and oncogenes. Mutations in tumour suppressor genes can allow tumours to grow unchecked - a case of no brakes - while mutations in oncogenes can activate cell prolif
California [US], January 19 (ANI): A collaborative study by scientists of Sanford Burnham Prebys Medical Discovery Institute and the University of Glasgow has identified two drugs that are potent against Acute Myeloid Leukemia (AML) and also administered how they effectively contribute to ca